🔎 Trials Near Me

Akèy › Ateroskleroz › Pennsylvania › Philadelphia

Etid klinik pou Ateroskleroz nan Philadelphia, PA

6 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Suburban Research Associates, West Chester · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Ap rekriteFaz 3
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia
  • Clinical Research of Philadelphia, Philadelphia
  • Keystone Clinical Studies, Plymouth Meeting · 12 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Abington Medical Specialists, Horsham · 16 mi lwen
  • Family Practice Associates, Wilmington · 25 mi lwen
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3
  • Clinical Renal Associates, LTD, Exton · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Philadelphia
  • Research Site, Philadelphia
  • Research Site, Horsham · 16 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Pelacarsen Roll-over Extension Program

Ap rekriteFaz 3
  • TCV Clinical Studies, Linwood · 16 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Jul 29, 2026 · NCT06875973

Etid Ateroskleroz nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.